These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 32866938)

  • 1. Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutations.
    Mangone G; Bekadar S; Cormier-Dequaire F; Tahiri K; Welaratne A; Czernecki V; Pineau F; Karachi C; Castrioto A; Durif F; Tranchant C; Devos D; Thobois S; Meissner WG; Navarro MS; Cornu P; Lesage S; Brice A; Welter ML; Corvol JC;
    Parkinsonism Relat Disord; 2020 Jul; 76():56-62. PubMed ID: 32866938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of deep brain stimulation of the subthalamic nucleus (STN-DBS) in patients with monogenic PRKN and LRRK2 forms of Parkinson's disease.
    Prendes Fernández P; Blázquez Estrada M; Sol Álvarez J; Álvarez Martínez V; Suárez San Martín E; García Fernández C; Álvarez Carriles JC; Lozano Aragoneses B; Saiz Ayala A; Santamarta Liébana E; González Álvarez L
    Parkinsonism Relat Disord; 2023 Feb; 107():105282. PubMed ID: 36657280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers.
    Pal G; Mangone G; Hill EJ; Ouyang B; Liu Y; Lythe V; Ehrlich D; Saunders-Pullman R; Shanker V; Bressman S; Alcalay RN; Garcia P; Marder KS; Aasly J; Mouradian MM; Link S; Rosenbaum M; Anderson S; Bernard B; Wilson R; Stebbins G; Nichols WC; Welter ML; Sani S; Afshari M; Verhagen L; de Bie RMA; Foltynie T; Hall D; Corvol JC; Goetz CG
    Ann Neurol; 2022 Mar; 91(3):424-435. PubMed ID: 34984729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis.
    Artusi CA; Dwivedi AK; Romagnolo A; Pal G; Kauffman M; Mata I; Patel D; Vizcarra JA; Duker A; Marsili L; Cheeran B; Woo D; Contarino MF; Verhagen L; Lopiano L; Espay AJ; Fasano A; Merola A
    JAMA Netw Open; 2019 Feb; 2(2):e187800. PubMed ID: 30707228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GBA-Associated Parkinson's Disease: Progression in a Deep Brain Stimulation Cohort.
    Lythe V; Athauda D; Foley J; Mencacci NE; Jahanshahi M; Cipolotti L; Hyam J; Zrinzo L; Hariz M; Hardy J; Limousin P; Foltynie T
    J Parkinsons Dis; 2017; 7(4):635-644. PubMed ID: 28777757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The LRRK2 G2019S mutation status does not affect the outcome of subthalamic stimulation in patients with Parkinson's disease.
    Greenbaum L; Israeli-Korn SD; Cohen OS; Elincx-Benizri S; Yahalom G; Kozlova E; Strauss H; Molshatzki N; Inzelberg R; Spiegelmann R; Israel Z; Hassin-Baer S
    Parkinsonism Relat Disord; 2013 Nov; 19(11):1053-6. PubMed ID: 23932063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.
    Alcalay RN; Caccappolo E; Mejia-Santana H; Tang M-; Rosado L; Orbe Reilly M; Ruiz D; Ross B; Verbitsky M; Kisselev S; Louis E; Comella C; Colcher A; Jennings D; Nance M; Bressman S; Scott WK; Tanner C; Mickel S; Andrews H; Waters C; Fahn S; Cote L; Frucht S; Ford B; Rezak M; Novak K; Friedman JH; Pfeiffer R; Marsh L; Hiner B; Siderowf A; Payami H; Molho E; Factor S; Ottman R; Clark LN; Marder K
    Neurology; 2012 May; 78(18):1434-40. PubMed ID: 22442429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are LRRK2 p.G2019S or GBA1 variants associated with long-term outcomes of deep brain stimulation for Parkinson's disease?
    Anis S; Goldberg T; Shvueli E; Kozlov Y; Redlich Y; Lavi N; Lavie I; Sosero YL; Gan-Or Z; Ungar L; Zibly Z; Greenbaum L; Fay-Karmon T; Hassin-Baer S
    Parkinsonism Relat Disord; 2024 Jul; 124():106008. PubMed ID: 38242744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression.
    Ortega RA; Wang C; Raymond D; Bryant N; Scherzer CR; Thaler A; Alcalay RN; West AB; Mirelman A; Kuras Y; Marder KS; Giladi N; Ozelius LJ; Bressman SB; Saunders-Pullman R
    JAMA Netw Open; 2021 Apr; 4(4):e215845. PubMed ID: 33881531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longterm outcome of cognition, affective state, and quality of life following subthalamic deep brain stimulation in Parkinson's disease.
    Gruber D; Calmbach L; Kühn AA; Krause P; Kopp UA; Schneider GH; Kupsch A
    J Neural Transm (Vienna); 2019 Mar; 126(3):309-318. PubMed ID: 30684055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrode position and cognitive outcome following deep brain stimulation surgery.
    Chen JW; Zargari M; Cole MW; Gupta R; Subramanian D; Dawant BM; Li R; Konrad PE; Englot DJ; Dhima K; Bick SK
    J Neurosurg; 2024 Jul; 141(1):230-240. PubMed ID: 38335523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive predictors of cognitive change following bilateral subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Yágüez L; Costello A; Moriarty J; Hulse N; Selway R; Clough C; Samuel M; Ashkan K
    J Clin Neurosci; 2014 Mar; 21(3):445-50. PubMed ID: 24231557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caregiver burden worsens in the second year after subthalamic nucleus deep brain stimulation for Parkinson's disease.
    Jackowiak E; Maher AC; Persad C; Kotagal V; Wyant K; Heston A; Patil PG; Chou KL
    Parkinsonism Relat Disord; 2020 Sep; 78():4-8. PubMed ID: 32659619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive and psychiatric outcome 3 years after globus pallidus pars interna or subthalamic nucleus deep brain stimulation for Parkinson's disease.
    Boel JA; Odekerken VJ; Schmand BA; Geurtsen GJ; Cath DC; Figee M; van den Munckhof P; de Haan RJ; Schuurman PR; de Bie RM;
    Parkinsonism Relat Disord; 2016 Dec; 33():90-95. PubMed ID: 27688200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term cognitive outcome of bilateral subthalamic deep brain stimulation in Parkinson's disease.
    Kim HJ; Jeon BS; Paek SH; Lee KM; Kim JY; Lee JY; Kim HJ; Yun JY; Kim YE; Yang HJ; Ehm G
    J Neurol; 2014 Jun; 261(6):1090-6. PubMed ID: 24687897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Greater improvement in LRRK2 G2019S patients undergoing Subthalamic Nucleus Deep Brain Stimulation compared to non-mutation carriers.
    Sayad M; Zouambia M; Chaouch M; Ferrat F; Nebbal M; Bendini M; Lesage S; Brice A; Brahim Errahmani M; Asselah B
    BMC Neurosci; 2016 Feb; 17():6. PubMed ID: 26831335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomical predictors of cognitive decline after subthalamic stimulation in Parkinson's disease.
    Planche V; Munsch F; Pereira B; de Schlichting E; Vidal T; Coste J; Morand D; de Chazeron I; Derost P; Debilly B; Llorca PM; Lemaire JJ; Marques A; Durif F
    Brain Struct Funct; 2018 Sep; 223(7):3063-3072. PubMed ID: 29736590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease.
    Witt K; Daniels C; Krack P; Volkmann J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    J Neurol Sci; 2011 Nov; 310(1-2):261-6. PubMed ID: 21733529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative cognitive profile predictive of cognitive decline after subthalamic deep brain stimulation in Parkinson's disease.
    Mana J; Bezdicek O; Růžička F; Lasica A; Šmídová A; Klempířová O; Nikolai T; Uhrová T; Růžička E; Urgošík D; Jech R
    Eur J Neurosci; 2024 Oct; 60(7):5764-5784. PubMed ID: 39212074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.